Hims & Hers stock plunges after Novo Nordisk ends its brief partnership
The Danish pharmaceutical said it was ending the partnership because Hims is selling and promoting a cheaper copycat of its blockbuster drug Wegovy.
Site référencé: Business Insider
Business Insider
Take a look inside the factory building America's first robotaxi fleet
24/06/2025
My friend Bryan is 97 and I'm 40. He still lives independently and is an inspiration to me.
24/06/2025
An ex-Googler who earned $450,000 before he quit shares 6 things Big Tech candidates are doing wrong &mdash ; and how to fix (...)
24/06/2025
San Francisco was written off as dead. Now, real estate investors are flocking back.
24/06/2025
Meta's largest AI competitors are fighting for users inside its most popular chatbot app : WhatsApp
24/06/2025
Check out the exclusive pitch deck defense tech startup Onebrief used to raise new cash at a $1.1 billion valuation
24/06/2025
